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ess: yiwasaki@koto.kpuSummary Purpose: To evaluate the effectiveness of fluoroscopy-guided barium
marking for localization of small peripheral pulmonary lesions before video-assisted
thoracic surgery (VATS) resection.
Material & methods: Twenty-one patients with peripheral pulmonary lesions
15mm or less in diameter who were scheduled to undergo VATS resection were
studied. A catheter was inserted bronchoscopically into the target segment and
guided to a presumed lesion. The tip of the catheter was confirmed fluoroscopically
to be at the exact spot determined beforehand. A 50% (weight/volume) barium
sulfate suspension was instilled into the bronchus through the catheter, and the site
of barium marking was ascertained by CT scanning.
Results: The average instilled volume of barium was 0.4270.07ml. On CT scans,
barium spots were superimposed on the target lesions in 19 of the 21 patients and
were only 6–7mm from the lesions in the other 2. Barium was well preserved in all
patients at the time of VATS resection. A mild cough persisted for about 1 week in
one patient, but the other patients had no specific complications.
Conclusion: Fluoroscopy-guided barium marking is a safe, convenient, and
reliable method for localization of small pulmonary lesions before VATS resection.
r 2004 Elsevier Ltd. All rights reserved.4 Elsevier Ltd. All rights reserv
5-251-5513; fax: +81-75-
-m.ac.jp (Y. Iwasaki).Introduction
As we enter the era of CT screening for lung
cancer, small pulmonary lesions not seen on chested.
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Table 1 Patients’ characteristics (n ¼ 21).
Age, year 6472 (38–77)
Sex, Male: Female 11:10
Detectable lesion on chest
X-ray film
0
Lesion diameter, mm 10.770.7 (3–15)
Distance to pleural
surface, mm
9.471.1 (2–20)
Lobar location
RU 8
RM 2
RL 6
LU 4
LL 1
Values are means7SE.(): range, RU, right upper lobe; RM,
right middle lobe; RL, right lower lobe; LU, left upper
lobe; LL, left lower lobe.
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increasing frequency.1–3 Such lesions are difficult
to diagnose by conventional techniques such as
transbronchial or percutaneous biopsy. Recently,
video-assisted thoracic surgery (VATS) resection has
been used to treat small pulmonary lesions.4–6
Accurate resection by VATS requires techniques
that can pinpoint the location of lesions. Several
such techniques including lipiodol injection,7 wire-
hook localization,8–12 pleural marking by dye,13–16
and coil marking,17 have been developed. All
reported methods use CT scanning for guidance,
and many are done percutaneously. Procedures
performed under CT guidance are cumbersome and
require a CT room; percutaneous approaches may
cause such complications as pneumothorax, bleed-
ing, and embolism.18,19
This study examined the reliability, safety, and
convenience of fluoroscopy-guided barium marking
via a transbronchial approach for the localization of
small pulmonary nodules not seen on the pleural
surface.Material and methods
To be eligible, patients had to have peripheral
pulmonary lesions 15mm or less in diameter that
were scheduled to undergo wedge resection by
VATS and were difficult to identify thoracoscopi-
cally. All patients gave informed consent.
This prospective study consecutively enrolled 21
patients from January 2000 through December
2003. There were 11 men and 10 women aged
38–77 years. None of the lesions studied could be
detected on chest X-ray films, even retrospectively.
The average diameter of the lesions was
10.770.7mm, and the average distance from the
pleural surface was 9.471.1mm. Eight lesions
were located in the right upper lobe, 2 in the right
middle lobe, 6 in the right lower lobe, 4 in the left
upper lobe, and 1 in the left lower lobe (Table 1).
The optimal site for the catheter tip was decided
on chest radiographs, using CT scans for reference
(Fig. 1). Under bronchoscopic guidance, a catheter
was inserted into the target segment and guided to
a presumed lesion. The catheter tip was checked
frontally and laterally by fluoroscopic examination
to confirm that it was located on the exact spot
designated beforehand. A 50% (weight/volume)
barium sulfate suspension was instilled into the
bronchus through the catheter, and the site of
barium marking was ascertained by CT scanning
(Fig. 2).Results
The average instilled volume of barium was
0.4270.07ml. On CT scans, barium spots were
superimposed on the target lesions in 19 of the 21
patients and were 6–7mm from the lesions in the
other 2. The average time from marking to VATS
resection was 13.173.6 days (range 1–71 days).
Barium was well preserved in all patients when
VATS resection was performed. A mild cough
persisted for about 1 week in one patient, but
the other patients had no specific complications
(Table 2).
Three of the 12 solid lesions on CT scans were
primary lung cancer. Two were adenocarcinomas,
and one was a small cell carcinoma. All five lesions
appearing as ground-glass opacities (GGOs) were
adenocarcinomas. Two out of the three lesions
appearing as high-density GGOs were adenocarci-
nomas (Table 3). Specimens were examined im-
mediately after resection, and 10 patients with
primary lung cancer underwent VATS lobectomy
with mediastinal lymph node dissection. The
patient with small cell carcinoma received chemor-
adiotherapy.Discussion
As we enter the era of spiral CT screening for lung
cancer, we will be removing smaller lesions. Small
lesions not close to the pleural surface must be
accurately localized. Suzuki et al. recommended
that small lesions situated more than 5mm
from the pleural surface be marked before VATS
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Figure 1 Chest CT scan and X-ray film obtained before
marking. (A) Chest CT scan. A ground-glass opacity was
seen in the right S2b. The arrowhead indicates the lesion.
(B) Chest X-ray film. The lesion could not be detected.
Circular area shows the target site of marking.
Figure 2 Chest CT scan and X-ray film obtained after
marking. (A) Chest CTscan. Instilled barium was observed
to overlay the lesion. (B) Chest X-ray film. Barium is
instilled into the target site. Adenocarcinoma was
diagnosed on VATS resection.
Fluoroscopy-guided barium marking 287resection.20 Marking is needed to localize lesions
appearing as GGOs, regardless of size and proximity
to the pleural surface.
Several marking techniques done under CT
guidance have been described. Percutaneous
wire-hook localization is an effective procedure,
but the wires used are designed for breast tissue,
which is denser than lung tissue. Consequently, the
wire is dislodged from the nodule in 4–20% of
patients, necessitating a large resection.8–12 This
procedure carries the risk of pneumothorax and
pulmonary hemorrhage, and has caused fatal airembolism.18,19 Injection of methylene blue is
another commonly used marking procedure.13,14
VATS resection must be done within 3 h after
marking, because of rapid diffusion of the dye.
Close coordination between radiologic and surgical
services is therefore required. Another drawback is
that some nodules cannot be located during
operation because of diffusion of the dye or severe
anthracosis of the visceral pleura.14 Moon et al.
successfully located small nodules by injection of
lipiodol under CT-guidance in 10 patients. Indigo
carmine was used to mark the pleural surface, but
usually disappeared within a couple of hours after
injection.15
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Table 3 CT findings and pathological diagnosis.
CT findings Number of cases
Solid lesion
Adenocarcinoma 2
Small cell carcinoma 1
Intrapulmonary LN 2
Inflammatory lesion 4
Tuberculoma 1
Granuloma 2
GGO alone
Adenocarcinoma 5
GGO with high density
Adenocarcinoma 2
Inflammatory lesion 1
Cavitary lesion
MAC infection 1
Total 21
LN, lymph node; GGO, ground-glass opacity; MAC,
Mycobacterium avium complex.
Table 2 Barium marking.
Instilled dose of barium (ml) 0.4270.07 (0.2–1.5)
Time to VATS (days) 13.173.6 (1–71)
Complications
None 20 cases
Cough 1 case
Values are means7SE. (): range.
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CT-guided barium marking under bronchoscopic
guidance.21,22 Kobayashi described a patient who
underwent this procedure with no complications.21
Okamura et al. performed barium marking by CT-
guided bronchoscopy for 21 small peripheral lesions
approximately 10mm in diameter. All lesions were
successfully marked and identified at the time of
VATS resection. No complications were associated
with this procedure.22 However, their procedure is
complicated because bronchoscopic examination
and CT scanning must be done simultaneously.
We performed barium marking under fluoroscopic
guidance, not CT scanning, during routine broncho-
scopic examinations. To date, many different
marking procedures have been devised to localize
small pulmonary lesions, but all have required CT
guidance. To our knowledge, this is the first report
to describe a technique for barium marking under
fluoroscopic guidance. Nineteen of the 21 lesions
were pinpointed by barium. In the other two,
barium spots were only 6–7mm from the lesions. A
key point of our procedure is that the spot to bemarked with barium is designated on chest radio-
graphs, using CT scans as reference, before the site
is actually marked. Instilled barium into bronchi is
maintained very well and does not disappear. The
time from barium marking to VATS resection ranged
from 1 to 71 days, and barium spots clearly
remained in all patients at the time of VATS
resection. One patient had a mild cough for 1 week
after marking, but no other specific complications
were reported.
Two approaches have been used to mark lesions:
percutaneous and transbronchial. Although a per-
cutaneous approach was used in most previous
studies, this approach has a risk of embolism. We
regard the transbronchial approach to be safer, and
there were no complications except for the mild
cough described above.
We conclude that fluoroscopy-guided barium
marking is a reliable, convenient, and minimally
invasive method for localizing small peripheral
pulmonary lesions before VATS resection.References
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